Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Share-based Compensation (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Share-based Compensation for 14 consecutive years, with $174000.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 38.1% to $174000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $643000.0 through Dec 2025, up 50.59% year-over-year, with the annual reading at $643000.0 for FY2025, 50.59% up from the prior year.
  • Share-based Compensation hit $174000.0 in Q4 2025 for STRATA Skin Sciences, down from $212000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $662000.0 in Q1 2021 to a low of $26000.0 in Q3 2024.
  • Historically, Share-based Compensation has averaged $274100.0 across 5 years, with a median of $250500.0 in 2023.
  • Biggest five-year swings in Share-based Compensation: plummeted 92.28% in 2024 and later soared 715.38% in 2025.
  • Year by year, Share-based Compensation stood at $80000.0 in 2021, then surged by 138.75% to $191000.0 in 2022, then surged by 51.31% to $289000.0 in 2023, then tumbled by 56.4% to $126000.0 in 2024, then soared by 38.1% to $174000.0 in 2025.
  • Business Quant data shows Share-based Compensation for SSKN at $174000.0 in Q4 2025, $212000.0 in Q3 2025, and $128000.0 in Q2 2025.